VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

AACR 2021 | Impact of the TME on CAR T-cell therapy for kidney cancer

Yufei Wang, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses the role of the tumor microenvironment (TME) in the treatment of kidney cancer, in particular for renal cell carcinoma (RCC). Dr Wang outlines the impacts that the TME on novel therapies, including chimeric antigen receptor (CAR) T-cell therapies. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter